Testing a new drug AROG4-01 for advanced solid tumors
Part of Cancer, Digestive system, Hormones & metabolism, Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial tests a new drug called AROG4-01 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to find the right dose and see if the drug can help shrink or slow tumor growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older with an advanced solid tumor (a cancer that has spread or cannot be removed).
- You have tried standard treatments and they are no longer working, or you cannot have standard treatment.
- You are able to take care of yourself (ECOG performance status 0-2) and expected to live at least 12 weeks.
- Your blood counts and organ function (kidney, liver, bone marrow) are within acceptable ranges.
- You have not had any cancer therapy (chemotherapy, radiation, major surgery) in the last 4 weeks, and any side effects from past treatment are mild.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests APG-2449, a new drug, in people with advanced solid tumors—especially certain lung cancers that have ALK or ROS1 gene fusions. Because it’s an early safety-and-dose study, it may help learn how well the drug works and what doses are safe.
This trial tests a new drug called CHO-A04 for people with advanced solid tumors that have not responded to standard treatments or who cannot take them. It aims to see if the drug is safe and effective.
This trial tests a new drug, GSK5533524, alone or with other treatments, for people with advanced solid tumors that have stopped responding to standard therapies. It aims to find out if the drug is safe and shows early signs of working.
This early-phase trial tests a new oral drug (CSCJC3456) for people with advanced solid tumors, especially those with certain FGFR gene changes. It aims to see if the drug is safe and may help when other treatments have stopped working.
This trial tests an experimental drug called BL-M08D1 for people with solid tumors that have spread or cannot be removed by surgery and have stopped responding to standard treatments. The goal is to see if the drug is safe and effective.
This study tests a new drug called AGX101 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and if it can shrink tumors or slow their growth.
Hear when a new Solid Tumors (Phase 1) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.